Full text loading...
Patients with Inflammatory Bowel Disease frequently report disturbances in sleep. Few studies have utilized objective investigations like wrist actigraphy or polysomnography to explore sleep patterns in patients with IBD. To address this, we conducted a systematic review and meta-analysis to determine how disease activity impacts sleep efficiency among IBD patients.
We conducted a search of Medline, the Cochrane Library, the National Library of Medicine Clinical Trial Database, and EMBASE for relevant studies from the date of establishment to July 2023. Sleep efficiency data in active and quiescent Crohn’s disease was summarised using a fixed-effects model.
Of the 780 articles identified in the initial search, 7 eligible studies were selected. Separate data regarding UC was lacking. There were 5 suitable studies eligible for meta-analysis, comprising 219 participants (107 and 112 patients with active and quiescent Crohn’s Disease, respectively). In this meta-analysis, the 95% CI of four out of five studies included unity, but the pooled analysis revealed greater sleep efficiency in those with remission Crohn’s disease in comparison to active Crohn’s (pooled mean difference (MD), -3.64; 95% Confidence Interval (CI), -5.56, -1.73, p= 0.0002). The degree of heterogeneity between studies was minimal (I2 = 0%, p = 0.59).
We have demonstrated that worse sleep efficiency is associated with active CD compared to quiescent disease, but there is insufficient data regarding UC. Additional research, applying objective measures to evaluate sleep efficiency is necessary for a better understanding of the relationship between sleep quality and disease activity in IBD.